Ling, Yun
Liang, Gehao
Lin, Qun
Fang, Xiaolin
Luo, Qing
Cen, Yinghuan
Mehrpour, Maryam
Hamai, Ahmed
Liu, Zihao
Shi, Yu
Li, Juanmei
Lin, Wanyi
Jia, Shijie
Yang, Wenqian
Liu, Qiang
Song, Erwei
Li, Jun
Gong, Chang http://orcid.org/0000-0001-5215-7497
Funding for this research was provided by:
National Key R&D Program of China (2017YFC1309103, 2017YFC1309104)
Natural Science Foundation of China (81672594, 81772836, 81621004, 81830082, 882030078)
Natural Science Foundation of China (81872139)
Natural Science Foundation of China (82072907)
Clinical Innovation Project of Bioland Laboratory (2018GZR0201004)
Sun Yat-sen memorial hospital cultivation project for clinical research (SYS-C-201805)
Key Projects of The National Natural Science Foundation of China (51861125203)
Project of The Beijing Xisike Clinical Oncology Research Foundation (Y-Roche2019/2-0078)
Technology Development Program of Guangdong province (2021A0505030082)
Project of The Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation (2020B1212060018OF007)
Article History
Received: 23 August 2021
Accepted: 4 December 2021
First Online: 3 January 2022
Declarations
:
: This work was approved by Sun Yat-sen Memorial Hospital Ethics Committee. The animal experiments were approved by Forevergen Medical Corporation (Guangzhou, China), and all experimental procedures on animals were in accordance with the ethical guidelines of the institution.
: Consent to publish has been obtained from all authors.
: The authors declare that they have no competing interests.